Disease In Calves Research Articles

Early detection of disease onset through changes in appearance of pre-weaning calves.

The onset of diseases in pre-weaning calves can lead to changes in their appearance, which can aid early disease detection. This study measured the changes in appearance that led to disease onset in 66 pre-weaning Holstein calves. The appearance scores of the calves were recorded for 7 days before the onset of digestive or respiratory diseases. Appearance features (ear position, head position, topline curve, hair coat length, hair coat gloss, eye opening, and sunken eyes) were recorded using video camera images and scored from 0 (healthy) to 2 (poor). Among the calves with respiratory diseases, the proportion of calves with a score of 0 for ear position decreased linearly over time (p = 0.0437). Among the calves with digestive diseases, the proportion of calves with a score of 2 for hair coat length increased linearly over time (p = 0.0197). Among the calves with both respiratory and digestive diseases, the proportion of calves with scores of 1 for the topline curve and 2 for eye opening increased linearly over time (p = 0.0191). Therefore, early signs of disease manifest as different appearance features depending on the type of disease before its onset.

Dystocia due to crooked calf disease associated with inverted head and sternal deformity in a crossbred Jersey cow

Dystocia due to crooked calf disease associated with inverted head and sternal deformity in a crossbred Jersey cow

Failed transfer of passive immunity is a component cause of pre-weaning disease in beef and dairy calves: A systematic review and meta-analysis


 Pre-weaned beef and dairy calves that fail to receive mater­nal antibodies are more susceptible to disease. A systematic review and meta-analysis were performed to evaluate the as­sociation between failed transfer of passive immunity (FTPI) and disease in pre-weaned beef and dairy calves. Three data­bases were searched for relevant studies that evaluated calves diagnosed with FTPI at ≤8 days of age and recorded incidence of disease pre-weaning. Twenty-three, out of 182 identified ref­erences, were relevant and contained 46 studies. Twelve stud­ies evaluated the effect of FTPI on morbidity, 18 on mortality, 8 on diarrhea, and 8 on pneumonia. Forty-two of 46 studies (91.3%) reported greater risk for disease among FTPI calves. The strength of association between FTPI and disease var­ied and was not resolved by subgrouping by outcome, animal type, test, cut-off point, or cumulative incidence of disease. Failed transfer of passive immunity is a component cause of calf disease that may have a greater impact in some popula­tions than others.

An intranasal recombinant NDV-BRSV Fopt vaccine is safe and reduces lesion severity in a colostrum-deprived calf model of RSV infection

Human respiratory syncytial virus (HRSV) is a major cause of severe lower respiratory tract disease in infants and the elderly, yet no safe, effective vaccine is commercially available. Closely related bovine RSV (BRSV) causes respiratory disease in young calves, with many similar features to those seen in HRSV. We previously showed that a Newcastle disease virus (NDV)-vectored vaccine expressing the F glycoprotein of HRSV reduced viral loads in lungs of mice and cotton rats and protected from HRSV. However, clinical signs and pathogenesis of disease in laboratory animals following HRSV infection differs from that observed in human infants. Thus, we examined whether a similar vaccine would protect neonatal calves from BRSV infection. Codon-optimized rNDV vaccine (rNDV-BRSV Fopt) was constructed and administered to colostrum-deprived calves. The rNDV-BRSV Fopt vaccine was well-tolerated and there was no evidence of vaccine-enhanced disease in the upper airways or lungs of these calves compared to the non-vaccinated calves. We found two intranasal doses reduces severity of gross and microscopic lesions and decreases viral load in the lungs. Furthermore, serum neutralizing antibodies were generated in vaccinated calves. Finally, reduced lung CXC chemokine levels were observed in vaccinated calves after BRSV challenge. In summary, we have shown that rNDV-BRSV Fopt vaccine is safe in colostrum-deprived calves, and is effective in reducing lung lesions, and decreasing viral load in upper respiratory tract and lungs after challenge.

Developing a tool to assess the health-related quality of life in calves with respiratory disease: content validation

Bovine respiratory disease (BRD) is a major welfare and productivity issue for calves. Despite the extensive negative impacts on calf welfare and performance, BRD remains challenging to detect and treat effectively. However, the clinical signs of disease are only one aspect of the disease that is experienced by the individual. The assessment of emotional experience in animals is not straightforward, but it is increasingly recognised that the quality of behaviour and demeanour of an individual is a reflection of their internal emotional state. The aim of the present study was to complete the content validation stage of the development process for a health-related quality of life (HRQOL) tool. This was based around indicators from an existing conceptual framework containing twenty-three indicators in two domains (clinical signs and behavioural expression). The content validation stage involves engaging with key stakeholders. For this study, this took the form of a survey and discussions with focus groups, which are standard methods in this field. A survey and stakeholder focus groups were conducted to assess the usefulness of each indicator and its relevance for inclusion within a HRQOL tool. In the survey, participants were asked to rate the usefulness of each of the indicators using a 4-point scale which were then dichotomised into ‘useful’ and ‘less useful’. Based on the ‘useful’ result, each indicator within the domains was ranked. A similar approach was taken with the responses from the focus groups. Focus group participants were asked to select indicators that they felt were of use and the result of this was used to rank each of the indicators. The ranks of the indicators from both the survey and the focus groups along with the transcripts from the focus groups were used to determine the indicators from each domain to include within the HRQOL tool. Indicators within the clinical signs domain that were included were nasal discharge, cough, respiratory effort, ocular appearance (discharge and vibrancy), body and head posture and ear carriage. For the domain of behavioural expression, the indicators included were movement to feed, responsiveness, spatial proximity, volume of feed intake, motivation at feed and vigour. The next stage will be to validate the construction of the HRQOL tool through its use in practice. The inclusion of indicators that allow the experiential aspects of disease to be recorded in health assessments will likely increase the ability of farmers and others to detect respiratory disease in calves.

Deep convolutional neural networks for the detection of diarrhea and respiratory disease in preweaning dairy calves using data from automated milk feeders.

The objective of the current study was to develop a predictive model for calf disease detection in the preweaning period using data from automated milk feeders (AMF). A deep convolutional neural network (CNN) architecture for the detection of respiratory disease and diarrhea in dairy calves was developed. German Holstein calves were fed milk replacer either ad libitum (up to 25 L/d; n = 32) or restrictively (6 L/d; n = 32) via AMF from 10 ± 3 d of life on. Concentrate, hay, and water were freely available. Calf health parameters were scored daily. The AMF measured milk replacer (MR) intake, number of rewarded visits, number of unrewarded visits, and drinking speed. A calf was considered sick if its fecal score was 3 or 4 and its respiratory score was 2 or 3. Only data from AMF up to 47 d of age were included in the analysis. This cut in the data was made to avoid data from the weaning period. Data were split in 80:20 ratios for training and testing data sets according to the Pareto principle. A minimum sensitivity of 80% was considered an appropriate requirement for the prediction models. Considering all calves in group housing, cross-validation of the test data set showed a sensitivity of 83% and a specificity of 79%, with a positive predictive value and a negative predictive value of 37 and 97%, respectively. The area under the curve of the receiver operating characteristic for the deep CNN model was 0.81 for all group-housed calves. The CNN model yielded sensitivity and specificity of 83 and 71%, respectively (for ad libitum-fed calves), and 82 and 87%, respectively (for restricted-fed calves), with good area under the curve-receiver operating characteristic (0.77 to 0.87), indicating that the CNN models can predict calf disease in both groups with different MR allowances. The permutation feature importance was measured by the decrease in model accuracy, and features (behaviors) were summarized in descending order of their relative importance to the CNN model. Drinking speed and MR intake were the main factors to predict calf disease in calves fed ad libitum. The number of unrewarded visits to the milk feeder and MR intake were the main factors to predict calf disease in restricted-fed calves. Despite the relatively small sample size, the results provide strong evidence that daily feeding behavior data from AMF can be used to identify calves at risk for disease. In conclusion, despite a very good testing performance of the CNN model, the relatively low daily prevalence of calf disease in the present study resulted in a high proportion of false-positive alarms.

Feeding behaviors collected from automated milk feeders were associated with disease in group-housed dairy calves in the Upper Midwest United States

Automated milk feeders (AMF) are an attractive option for producers interested in adopting practices that offer greater behavioral freedom for calves and can potentially improve labor management. These feeders give farmers the opportunity to have a more flexible labor schedule and more efficiently feed group-housed calves. However, housing calves in group systems can pose challenges for monitoring calf health on an individual basis, potentially leading to increased morbidity and mortality. Feeding behavior recorded by AMF software could potentially be used as an indicator of disease. Therefore, the objective of this observational study was to investigate the association between feeding behaviors and disease in preweaning group-housed dairy calves fed with AMF. The study was conducted at a dairy farm located in the Upper Midwest United States and included a final data set of 599 Holstein heifer calves. The farm was visited on a weekly basis from May 2018, to May 2019, when calves were visually health scored and AMF data were collected. Calf health scores included calf attitude, ear position, ocular discharge, nasal discharge, hide dirtiness, cough score, and rectal temperatures. Generalized additive mixed models (GAMM) were used to identify associations between feeding behavior and disease. The final quasibinomial GAMM included the fixed (main and interactions) effects of feeding behavior at calf visit-level including milk intake (mL/d), drinking speed (mL/min), visit duration (min), rewarded (with milk being offered) and unrewarded (without milk) visits (number per day), and interval between visits (min), as well as the random effects of calf age in regard to their relationship with calf health status. Total milk intake (mL/d), drinking speed (mL/min), interval between visits (min) to the AMF, calf age (d), and rewarded visits were significantly associated with dairy calf health status. These results indicate that as total milk intake and drinking speed increased, the risk of calves being sick decreased. In contrast, as the interval between visits and age increased, the risk of calves being sick also increased. This study suggests that AMF data may be a useful screening tool for detecting disease in dairy calves. In addition, GAMM were shown to be a simple and flexible approach to modeling calf health status, as they can cope with non-normal data distribution of the response variable, capture nonlinear relationships between explanatory and response variables and accommodate random effects.

Comparison of pulmonary ultrasound aspects of dairy calves born from a normal or dystocic parturition

Ultrasound has relatively low use in the veterinary practice of cattle, especially in the diagnosis of respiratory diseases. There is little information on imaging patterns and occurrence of these diseases in calves from dystocic parturition, especially in the ability to diagnose the subclinical respiratory diseases. The correct clinical diagnosis aims to support efficient growth and expression of genetic potential for the replacer calves. Eighteen Holstein calves, five of which did not require assistance during birth and thirteen calves from dystocic parturition had the respiratory system evaluated by ultrasound. The objective was to describe and compare the pulmonary ultrasound aspects of calves from dystocic parturitions, compared to calves born without any aid. The degree of dystocia was classified on a scale from 1 to 5 points and the categorization of ultrasound images considered the presence or absence of pulmonary lesions. The ultrasound examination was able to diagnose animals affected with BRD in a subclinical manifestation, considering that none of the animals that presented pulmonary consolidation showed clinical signs of respiratory diseases. All cows with dystocia were classified as grade 2 dystocic parturition. There was no correlation between normal delivery (grade 1) and mild dystocia (grade 2) and occurrence of pulmonary consolidation.

The Effect of Pegbovigrastim Injection on Phagocytic and Oxidative Burst Activities of Peripheral Blood Granulocytes and Monocytes in Calves Challenged with Mycoplasma bovis.

Mycoplasma bovis (M. bovis) is an important pathogen affecting cattle, causing various diseases including pneumonia which mainly occurring in calves. Control of M. bovis infections is difficult due to the lack of commercial vaccines in most parts of the world and increasing trends of antimicrobial resistance in field isolates of the pathogen; therefore, it seems reasonable to look for new solutions for the prevention of the infection. Pegbovigrastim is a pegylated form of naturally occurring circulating cytokine in cattle that affects bovine leukocytes and some cell functions. Most studies on pegbovigrastim have focused on reducing the occurrence of mastitis and other diseases occurring during the periparturient period in cows, while this study attempts to use pegbovigrastim in the prevention of respiratory diseases in calves, which are largely caused by M. bovis. Based on previous observations on the immunostimulatory properties of pegbovigrastim in cattle, for the first time, the effect of its injection on the number and phagocytic and oxidative burst activities of peripheral blood granulocytes and monocytes in calves experimentally infected with M. bovis was investigated. Pegbovigrastim administration in the calves significantly stimulated an increase in peripheral blood granulocyte and monocyte counts and phagocytic activity of the cells, especially granulocytes, which was also generally expressed in the course of M. bovis infection. In response to pegbovigrastim administration, a general increase in the oxygen burst activity of the cells was observed. This effect was also shown despite ongoing infection with M. bovis which, taken together, may indicate a beneficial effect of pegbovigrastim injection on the immunity of the affected animals.

First DNA sequence proof for the occurrence of bovine adenovirus types 10 and 11 in continental Europe.

Bovine adenoviruses (BAdV) are known to cause respiratory and/or intestinal disease in calves. Infection can manifest as acute outbreaks, but more often only sporadic cases occur. Here we describe the PCR detection and partial sequence characterization of several BAdVs found in sick or dead calves on different farms in Western Hungary. Intermittent diarrhoeal illnesses occurred after weaning among calves on several farms located up to 40km apart. A high-sensitivity, broad-spectrum nested PCR, developed for the general detection of adenoviruses, gave positive results in four independent cases. Direct sequencing of PCR products showed clear results from only two samples, whereas sequences from the other two amplicons were mixed. Molecular cloning of these heterogeneous PCR products was performed to separate each DNA fragment therein. By sequencing several plasmid clones from both mixed samples, we were able to detect the simultaneous presence of two different BAdV types, namely types 6 and 10 classified into two separate (Atadenovirus and Mastadenovirus) genera. The sequence of one homogenous sample was identified as being derived also from BAdV-10, whereas the other sample contained a novel type, proposed to be BAdV-11. We demonstrated, for the very first time, the occurrence of the two latter virus types in continental Europe. Their appearance in Hungary marks a significant shift in the types of BAdVs actually circulating in the country. Considering the similarity of the pathological findings to those, attributed to BAdV-10 infections reported to date, the causative role of the viruses in these cases seems to be plausible. Phylogeny reconstruction further confirmed that BAdVs represent multiple genetic lineages.

Efficacy of Two Probiotic Products Fed Daily to Reduce Clostridium perfringens-Based Adverse Health and Performance Effects in Dairy Calves.

Clostridium perfringens is a spore-forming, anaerobic bacterium which produces toxins and exoenzymes that cause disease in calves, especially necro-hemorrhagic enteritis-associated diarrhea often resulting in death. Clostridium infections are currently being treated with antibiotics, but even with the prudent administration of antibiotics, there are significant rates of recurrence. Probiotics, an alternative to antibiotics, are commonly employed to prevent clostridial infections. The objectives of our study were to demonstrate that two commercially available products, when used as daily, direct-fed microbials, are effective in reducing adverse effects of an experimentally induced C. perfringens infection in dairy calves. We conducted a single site efficacy study with masking using a randomized design comprising 10 calves allocated to 3 treatment groups (probiotic 1, probiotic 2, and control). The procedures such as general health scores, body weight, blood samples, and fecal sample collections were done followed by experimental challenge of calves with C. perfringens. Daily feeding of L. animalis LA51 and P. freudenreichii PF24 without or with Bacillus lichenformis CH200 and Bacillus subtilis CH201, before, during and after an oral challenge of C. perfringens significantly reduced the incidence and severity of diarrhea while improving general impression and appearance scores of calves. Most notably, survival of calves in the two probiotic-fed groups was significantly higher than for control calves and further substantiates the potential economic and health benefits of feeding effective probiotics.

Effects of a farm-specific fecal microbial transplant (FMT) product on clinical outcomes and fecal microbiome composition in preweaned dairy calves.

Gastrointestinal disease (GI) is the most common illness in pre-weaned dairy calves. Therefore, effective strategies to manipulate the microbiome of dairy calves under commercial dairy operations are of great importance to improve animal health and reduce antimicrobial usage. The objective of this study was to develop a farm-specific FMT product and to investigate its effects on clinical outcomes and fecal microbial composition of dairy calves. The FMT product was derived from feces from healthy donors (5–24 days of age) raised in the same calf ranch facility as the FMT recipients. Healthy and diarrheic calves were randomly enrolled to a control (n = 115) or FMT (n = 112) treatment group (~36 g of processed fecal matter once daily for 3 days). Fecal samples were collected at enrollment and again 9 days later after the first FMT dose. Although the FMT product was rich in organisms typically known for their beneficial probiotic properties, the FMT therapy did not prevent or ameliorate GI disease in dairy calves. In fact, calves that received FMT were less likely to recover from GI disease, and more likely to die due to GI disease complications. Fecal microbial community analysis revealed an increase in the alpha-diversity in FMT calves; however, no major differences across treatment groups were observed in the beta-diversity analysis. Calves that received FMT had higher relative abundance of an uncultured organism of the genus Lactobacillus and Lactobacillus reuteri on day 10. Moreover, FMT calves had lower relative abundance of Clostridium nexile and Bacteroides vulgatus on day 10. Our results indicate the need to have an established protocol when developing FMT products, based on rigorous inclusion and exclusion criteria for the selection of FMT donors free of potential pathogens, no history of disease or antibiotic treatment.

Dynamics of some indicators of metabolism and non-specific immunity of calves with enterocolitis

Intestinal diseases of newborn calves, including enterocolitis, are the most common diseases of the digestive system of young cattle. Diseases, as a rule, develop from the first days of life of animals. The aim of the work was to study the dynamics of some indicators of the humoral immunity of newborn calves, as well as to assess the state of metabolism, taking into account the inclusion of probiotics and lipoic acid preparations in the treatment regimen for animals with enterocolitis. Sick animals of the first group (experimental I), in addition to the treatment provided for on the farm (diet therapy and antibiotic therapy), before feeding were asked inside 100 ml of probiotic starter culture based on the Enterococcus faecium L3 strain; to regulate lipid metabolism, a 0.5% solution of lipoic acid was administered intramuscularly at a dose of 2 ml once a day for 10 days. Sick animals of the second group (experimental II) were treated according to the scheme used in the farm. In calves of the I experimental group, in comparison with the animals of the II group, a significantly higher level of glucose, triglycerides and total protein in the blood was established. The amount of cholesterol was slightly higher compared to the initial level, but significantly lower than in the animals of the second experimental group. As a result of immunological studies, it was found that the indicators of nonspecific protection in sick calves of I and II experimental groups at 1-2 days of age had no significant differences. However, at the age of 10 days in calves, the studied parameters differed from each other BASK in the II experimental group was 42.7 ± 2.0% lysis, in animals of the I experimental group -50.4 ± 2.3% lysis (P <0.01), activity of beta-lysines 30.7±1.9%-lysis and 51.1±4.9%-lysis, respectively (P<0.01). Lysozyme activity of blood serum in calves of II and I experimental groups did not differ (P>0.05), and was at the level of 5.0±0.5%lysis and 5.2±0.9%-lysis, respectively. In the course of the studies, a positive effect of a probiotic based on the strain of microorganisms Enterococcus faecium L3 and 0.5% lipoic acid solution was established.

ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calves

Respiratory syncytial virus (RSV) infection causes a substantial lower-respiratory-tract disease burden in infants, constituting a global priority for vaccine development. We evaluated immunogenicity, safety and efficacy of a chimpanzee adenovirus (ChAd)-based vaccine candidate, ChAd155-RSV, in a bovine RSV (bRSV) challenge model. This model closely reproduces the pathogenesis/clinical manifestations of severe pediatric RSV disease. In seronegative calves, ChAd155-RSV elicits robust neutralizing antibody responses against human RSV. Two doses protect calves from clinical symptoms/lung pathological changes, and reduce nasal/lung virus loads after both a short (4-week) and a long (16-week) interval between last immunization and subsequent bRSV challenge. The one-dose regimen confers near-complete or significant protection after short-term or long-term intervals before challenge, respectively. The presence of pre-existing bRSV-antibodies does not affect short-term efficacy of the two-dose regimen. Immunized calves present no clinical signs of enhanced respiratory disease. Collectively, this supports the development of ChAd155-RSV as an RSV vaccine candidate for infants.

Improving beef calf health: frequency of disease syndromes, uptake of management practices following calving, and potential for antimicrobial use reduction in western Canadian herds.

Bovine respiratory disease (BRD), calf diarrhea (CD), and navel infections are the most commonly reported diseases of western Canadian beef calves. The objectives of this study were to estimate the frequency of treatment for these diseases for specific age cohorts and identify potential opportunities for reducing antimicrobial use. Producers representing 89 western Canadian cow-calf herds completed a survey describing calfhood diseases and management. The most common reason for calf treatment before weaning was BRD (4.9%), and BRD treatment was described in 51% of reporting herds before 2 months of age. Calf diarrhea (2.9%) and navel infection (2.0%) were the second and third most common reasons for treatment. Most calves were treated for CD between 6 days and 1 month of age. Almost one in five herds reported routinely administering antimicrobials at birth. Calving heifers and cows together were all associated with an increased treatment risk for BRD in calves from birth to 2 months (OR 3.55, 95%CI 2.13-5.94, P < 0.0001), CD from 1 month to weaning (OR 3.94, 95%CI 1.29-12.0, P = 0.02), and navel infection (OR 4.55, 95%CI 1.78-11.6, P = 0.002). Failure to sort cow-calf pairs out of the calving area was also associated with an increased treatment risk for BRD from 4 months to weaning (OR 4.89, 95%CI 1.96-12.2, P = 0.0006) and CD from 24 h to 5 days (OR 2.82, 95%CI 1.03-7.75, P = 0.04), and not using the Sandhills system was associated with an increased treatment risk for navel infection (OR 4.55, 95%CI 1.78-11.6, P = 0.002). Other potentially modifiable factors associated with an increased risk of BRD in calves from birth to 2 months were winter feeding and calving in one area (P < 0.0001), heifers calving in a higher density area (P = 0.01), and an increasing number of times cow-calf pairs were gathered before turn out to summer pasture (P = 0.0005). The purchase of any cows during the calving or prebreeding period was associated with an increased risk of BRD from birth to 2 months (P < 0.0001) and from 2 to 4 months (P < 0.0001). A history of respiratory bacterin vaccines administered to the dams was associated with a decreased risk of BRD in calves from 4 months to weaning (P = 0.01). Cows calving in a higher density area was associated with an increased risk of CD from 1 month to weaning (P = 0.02). These practices present opportunities for investigation of approaches to disease management that could support the judicious use of antimicrobials.

Efficacy of Abdominal Ultrasonography for Differentiation of Gastrointestinal Diseases in Calves.

Simple SummaryGastrointestinal diseases represent one of the common causes of bovine acute abdomen, such as abdominal distention, abdominal pain, and cessation of defecation. In addition to the observable signs when performing routine auscultation, rectal palpation, and biochemical examinations of ruminal fluid and blood, these clinical observations can provide evidence suggestive of these diseases, but they generally result in an inconclusive diagnosis. Therefore, exploratory laparotomy is often used because it facilitates both diagnosis and therapeutic decisions. For bovines, abdominal ultrasonography is frequently utilized as a convenient imaging modality to assist accurate diagnosis and contribute to subsequent appropriate therapeutic choices for bovine gastrointestinal diseases. According to recent trends in human medicine and small animal practice, technical improvements have led to developments in the diagnostic value of abdominal ultrasonography, including scanning methods and the establishment of valuable diagnostic signs specific to a particular disease, e.g., a target sign for intussusception.This study investigated the clinical efficacy of abdominal ultrasonography for abomasal dilation in three calves, intestinal volvulus in five calves, intussusception in one calf, and internal hernia in one calf. In the abdominal ultrasonograms of the abomasal dilation cases, this disease was commonly characterized by severely extended lumens, including heterogeneously hyperechoic ingesta without intraluminal accumulations of gas. In the animals with intestinal volvulus and intussusception, a to-and-fro flow was observed to be a common ultrasonographic characteristic that led to suspicion of an intestinal obstruction. The use of abdominal ultrasonography for five cases with intestinal volvulus gave no reason to suspect this disease, despite its efficacy in one case, based on an acutely angled narrowing. Although three of five animals with intestinal volvulus had intestinal ruptures, no ultrasonographic evidence could be obtained. When abdominal ultrasonography was used for one case with intussusception, this pathological condition could be strongly suspected, as a “target” sign was observed. This finding supported surgical intervention for this case, followed by treatment with manual reduction, resulting in a favorable outcome. In terms of the differential and definitive diagnosis for various intestinal diseases, abdominal ultrasonography may be poor at providing indicative evidence, but very helpful for confirming intestinal obstruction.

Air Quality, Management Practices and Calf Health in Italian Dairy Cattle Farms.

Simple SummaryCalf mortality is an important factor of economic loss in dairy operations. Among the factors which can affect calf health, air quality in calf housing has rarely been studied. In the present research, the relations among air quality in the calf pens, management practices, microclimatic conditions and calf health and mortality were studied in 25 Italian dairy cattle farms. Microbial air quality in the calf pens was found to be related to temperature and humidity, design and position of the pen, some management practices and calf health and mortality. Maintaining dry bedding and controlling microclimatic conditions in the calf pen can be useful practices to promote good air microbiological quality in the calf pen, improving calf health and reducing mortality.Among factors that can affect calf health, microbial quality of the pen air is poorly studied. In 25 Italian dairy farms, data concerning air quality in the calf pens, hygiene of pens and equipment, microclimatic conditions, calf health and management were collected during the winter season (January-March 2020 and December-March 2021). The average air Standard Plate Count (SPC) of 85 pens was 4.51 (SD = 0.52) log10 cfu/m3 whereas the average air ammonia concentration was 0.66 (SD = 0.53) ppm. Positive correlations were found between average Temperature Humidity Index (THI) in the pen and air SPC, night maximum THI and air SPC and between SPC and yeast, mould and ammonia concentration in the pen air. The concentrations of E. coli, Enterobacteriaceae and yeasts in the pen air were higher and calf cough increased as the renewal interval of bedding material became longer. High bedding dry matter and low THI were associated with low air SPC, good calf health scores and low mortality. Maintaining low bedding humidity and controlling microclimatic conditions can contribute to enhancing air microbiological quality in the pen and reduce calf diseases and mortality.

Calving pen management

Calving is one of the most stressful events to occur during the production cycle in dairy cows, and the environment in which this occurs can significantly impact the health of the neonatal calf. The incidence of enteric and respiratory disease in young calves can be reduced by managing this environment better, limiting contamination and resultant infection pressure. The environment in which calves were managed from birth onwards was observed and scored on 66 dairy farms in Northern Ireland over a 3 week period. Assessments were made on hygiene factors such as stocking density, presence of sick cows, bedding frequency, cleaning frequency, ease of cleaning and hygiene scoring. This study highlights that, despite the clear need for managing hygiene around the time of birth, hygiene in the calving pen is often an area that producers do not focus on improving in order to efficiently rear a healthy, productive and robust dairy cow.

Features of keeping calves in the conditions of the dairy complex of the Leningrad region

Purpose: This work is based on a study of the features of keeping young cattle (organization of livestock placement, feeding regimen, veterinary manipulations) in a breeding plant in the Leningrad Region, assessing these features and identifying their impact on the state of the livestock and animal productivity.2000 heads of cattle, of which 915 are part of the dairy herd with average daily milk yield per cow - 19-20 kg (when cows are milked 2 times a day, freshly calved - 3 times) and the mass fraction of fat is 3.7%. After birth, calves are kept in a dispensary for up to 20 days, tied at a distance of 1.5-2 m from each other. After 20 days, the calves are transferred to group cages, 7 heads each, with a gradual change in feeding regimen. After 25 days, they are transferred to the calf house. The most common diseases in young animals are bronchopneumonia, pulmonary enphysema and dyspepsia. To prevent the development of infectious diseases in calves, vaccination is carried out from the age of 14 days. Against parainfluenza-3 and pasteurellosis vaccines Bovilis IBR (live labeled vaccine for specific prophylaxis against infectious bovine rhinotracheitis) and Bovilis Bovipast RSP vaccine (inactivated vaccine against parainfluenza-3 , respiratory syncytial infection and pasteurellosis of cattle) are used at a dose of 5 ml subcutaneously. At the age of three weeks, calves are vaccinated against salmonellosis (paratyphoid) and parainfluenza (again - after 10 days). After 2 weeks, calves are vaccinated against leptospirosis (repeat - after six months). From the age of two months they are vaccinated against tuberculosis. From the age of three months - against brucellosis, anthrax (revaccination after six months), depriving and rabies. At 3 months, the first deworming is carried out. Vaccination can increase the survival rate of young animals up to 97%. The ongoing activities are the main ones for the further use of breeding and commercial animals, the realization of their genetic potential and the production of high-quality products.

Clinical and microbiological effects in high-risk beef calves administered intranasal or parenteral modified-live virus vaccines.

Experimental bovine respiratory syncytial virus (BRSV) infection can enhance Histophilus somni (Hs) disease in calves; we thus hypothesized that modified-live virus (MLV) vaccines containing BRSV may alter Hs carriage. Our objective was to determine the effects of an intranasal (IN) trivalent (infectious bovine rhinotracheitis virus [IBRV], parainfluenza-3 virus [PI3V], and BRSV) respiratory vaccine with parenteral (PT) bivalent bovine viral diarrhea virus (BVDV) type I + II vaccine, or a PT pentavalent (BVDV type I and II, IBRV, BRSV, and PI3V) respiratory vaccine, on health, growth, immunity, and nasal pathogen colonization in high-risk beef calves. Calves (n = 525) were received in five truckload blocks and stratified by body weight (213 ± 18.4 kg), sex, and presence of a pre-existing ear-tag. Pens were spatially arranged in sets of three within a block and randomly assigned to treatment with an empty pen between treatment groups consisting of: 1) no MLV respiratory vaccination (CON), 2) IN trivalent MLV respiratory vaccine with PT BVDV type I + II vaccine (INT), or 3) PT pentavalent, MLV respiratory vaccine (INJ). The pen was the experimental unit, with 15 pens/treatment and 11 to 12 calves/pen in this 70-d receiving study. Health, performance, and BRSV, Hs, Mycoplasma bovis (Mb), Mannheimia haemolytica (Mh), and Pasteurella multocida (Pm) level in nasal swabs via rtPCR was determined on days 0, 7, 14, and 28, and BRSV-specific serum neutralizing antibody titer, and serum IFN-γ concentration via ELISA, were evaluated on days 0, 14, 28, 42, 56, and 70. Morbidity (P = 0.83), mortality (P = 0.68) and average daily gain (P ≥ 0.82) did not differ. Serum antibodies against BRSV increased with time (P < 0.01). There was a treatment × time interaction (P < 0.01) for Hs detection; on days 14 and 28, INT (21.1% and 57.1%) were more frequently (P < 0.01) Hs positive than CON (3.6% and 25.3%) or INJ (3.4 % and 8.4%). Also, INT had reduced (P = 0.03) cycle time of Hs positive samples on day 28. No difference (P ≥ 0.17) was found for IFN-γ concentration and Mb, Mh, or Pm detection. The proportion of Mh positive culture from lung specimens differed (P < 0.01); INT had fewer (0.0%; 0 of 9) Mh positive lungs than INJ (45.5%; 6 of 13) or CON (74.0%; 14 of 19). Vaccination of high-risk calves with MLV did not clearly impact health or growth during the receiving period. However, INT was associated with an altered upper respiratory microbial community in cattle resulting in increased detection and level of Hs.